Bank of New York Mellon Corp - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 53 filers reported holding NEON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$184,000
+121.7%
69,630
-0.6%
0.00%
Q4 2019$83,000
-11.7%
70,031
+28.6%
0.00%
Q3 2019$94,000
-72.3%
54,443
-23.8%
0.00%
Q2 2019$339,000
+55.5%
71,443
+112.1%
0.00%
Q1 2019$218,000
+122.4%
33,688
+73.4%
0.00%
Q4 2018$98,000
-30.5%
19,427
+17.6%
0.00%
Q3 2018$141,00016,5220.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$49,000,00041.06%
Partner Investment Management, L.P. 832,358$4,187,0005.23%
HARVARD MANAGEMENT CO INC 505,871$2,545,0000.54%
Casdin Capital, LLC 263,344$1,325,0000.23%
MEITAV INVESTMENT HOUSE LTD 648,878$3,264,0000.20%
Hillhouse Capital Management 399,308$2,009,0000.15%
PFM Health Sciences, LP 979,002$4,924,0000.13%
HHLR ADVISORS, LTD. 312,500$1,572,0000.06%
ArrowMark Colorado Holdings LLC 902,861$4,541,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 54,954$276,0000.01%
View complete list of NEON THERAPEUTICS INC shareholders